Literature DB >> 13834349

A clinical study in the use of valmethamide, an anxiety-reducing drug.

W STEPANSKY.   

Abstract

Entities:  

Keywords:  TRANQUILIZING AGENTS/therapy

Mesh：

Substances：

Year:  1960        PMID： 13834349

Source DB:  PubMed          Journal:  Curr Ther Res Clin Exp        ISSN： 0011-393X


× No keyword cloud information.
  9 in total

1.  Valnoctamide Inhibits Cytomegalovirus Infection in Developing Brain and Attenuates Neurobehavioral Dysfunctions and Brain Abnormalities.

Authors:  Sara Ornaghi; Lawrence S Hsieh; Angélique Bordey; Patrizia Vergani; Michael J Paidas; Anthony N van den Pol
Journal:  J Neurosci       Date:  2017-06-19       Impact factor: 6.167

2.  Comparative teratogenicity analysis of valnoctamide, risperidone, and olanzapine in mice.

Authors:  Bogdan J Wlodarczyk; Krystal Ogle; Linda Ying Lin; Meir Bialer; Richard H Finnell
Journal:  Bipolar Disord       Date:  2015-08-20       Impact factor: 6.744

3.  Pharmacokinetics of a valpromide isomer, valnoctamide, in healthy subjects.

Authors:  M Bialer; A Haj-Yehia; N Barzaghi; F Pisani; E Perucca
Journal:  Eur J Clin Pharmacol       Date:  1990       Impact factor: 2.953

4.  Stereoselective anticonvulsant and pharmacokinetic analysis of valnoctamide, a CNS-active derivative of valproic acid with low teratogenic potential.

Authors:  Tawfeeq Shekh-Ahmad; Naama Hen; Boris Yagen; John H McDonough; Richard H Finnell; Bogdan J Wlodarczyk; Meir Bialer
Journal:  Epilepsia       Date:  2013-12-06       Impact factor: 5.864

Review 5.  Clinical pharmacology of valpromide.

Authors:  M Bialer
Journal:  Clin Pharmacokinet       Date:  1991-02       Impact factor: 6.447

6.  Structure-pharmacokinetic relationships in a series of valpromide derivatives with antiepileptic activity.

Authors:  A Haj-Yehia; M Bialer
Journal:  Pharm Res       Date:  1989-08       Impact factor: 4.200

7.  Impairment of carbamazepine-10, 11-epoxide elimination by valnoctamide, a valpromide isomer, in healthy subjects.

Authors:  F Pisani; A Fazio; C Artesi; G Oteri; E Spina; T Tomson; E Perucca
Journal:  Br J Clin Pharmacol       Date:  1992-07       Impact factor: 4.335

8.  Mood stabilizers inhibit cytomegalovirus infection.

Authors:  Sara Ornaghi; John N Davis; Kelly L Gorres; George Miller; Michael J Paidas; Anthony N van den Pol
Journal:  Virology       Date:  2016-09-19       Impact factor: 3.616

9.  Pharmacokinetic-pharmacodynamic relationships of (2S,3S)-valnoctamide and its stereoisomer (2R,3S)-valnoctamide in rodent models of epilepsy.

Authors:  Nina Isoherranen; H Steve White; Brian D Klein; Michael Roeder; José H Woodhead; Volker Schurig; Boris Yagen; Meir Bialer
Journal:  Pharm Res       Date:  2003-08       Impact factor: 4.200
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.